CNE100005B03
CNE100005B03
REMEGEN CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.241.560.000 | 1.710.152.000 | 89.5% |
| Cost of Revenue | 425.505.000 | 342.796.000 | 24.1% |
| Gross Profit | 2.816.055.000 | 1.367.356.000 | 105.9% |
| 2.659.709.000 | 2.738.184.000 | 2.9% | |
| Operating Income | 156.346.000 | -1.370.828.000 | 111.4% |
| Pretax Income | 710.399.000 | -1.468.362.000 | 148.4% |
| Net Income Common Stockholders | 709.650.000 | -1.468.362.000 | 148.3% |
| -- | -- | -- | |
| -- | -- | -- |